In 2024, CAR T-cell therapy continues to transform the landscape of treatment for hematologic malignancies, including multiple myeloma and various…
Browsing: hematology
Emerging BTK inhibitors are positioned to change the landscape and impact your chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) treatment…
This immersive practice guide offers “how to†methods and day-to-day strategies via faculty commentary and a review of data and…
A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr.…
A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr.…
The GRIFFIN Study is a post-hoc analysis of sustained MRD negative status in the griffin study which treated patients with…
The study that I will be discussing today is the frailty subgroup analysis of the CANDOR study, which is a…
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Armon Sharei, Ph.D. Chief Executive Officer of SQZ…